148 related articles for article (PubMed ID: 11859001)
21. Synthesis and evaluation of a novel series of pyrrolizine derivatives as dual cyclooxygenase-1 and 5-lipoxygenase inhibitors.
Laufer S; Striegel HG; Neher K; Zechmeister P; Donat C; Stolingwa K; Baur S; Tries S; Kammermeier T; Dannhardt G; Kiefer W
Arch Pharm (Weinheim); 1997 Oct; 330(9-10):307-12. PubMed ID: 9396390
[TBL] [Abstract][Full Text] [Related]
22. Thalidomide and its analogues as cyclooxygenase inhibitors.
Noguchi T; Shimazawa R; Nagasawa K; Hashimoto Y
Bioorg Med Chem Lett; 2002 Apr; 12(7):1043-6. PubMed ID: 11909713
[TBL] [Abstract][Full Text] [Related]
23. Design, synthesis, and biological evaluation of some novel indolizine derivatives as dual cyclooxygenase and lipoxygenase inhibitor for anti-inflammatory activity.
Shrivastava SK; Srivastava P; Bandresh R; Tripathi PN; Tripathi A
Bioorg Med Chem; 2017 Aug; 25(16):4424-4432. PubMed ID: 28669741
[TBL] [Abstract][Full Text] [Related]
24. Cyclooxygenase-2, player or spectator in cyclooxygenase-2 inhibitor-induced apoptosis in prostate cancer cells.
Song X; Lin HP; Johnson AJ; Tseng PH; Yang YT; Kulp SK; Chen CS
J Natl Cancer Inst; 2002 Apr; 94(8):585-91. PubMed ID: 11959891
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and biological evaluation of new phenidone analogues as potential dual cyclooxygenase (COX-1 and COX-2) and human lipoxygenase (5-LOX) inhibitors.
Cusan C; Spalluto G; Prato M; Adams M; Bodensieck A; Bauer R; Tubaro A; Bernardi P; Da Ros T
Farmaco; 2005 Jan; 60(1):7-13. PubMed ID: 15652362
[TBL] [Abstract][Full Text] [Related]
26. Synthesis of 4,5-diaryl-1H-pyrazole-3-ol derivatives as potential COX-2 inhibitors.
Patel MV; Bell R; Majest S; Henry R; Kolasa T
J Org Chem; 2004 Oct; 69(21):7058-65. PubMed ID: 15471453
[TBL] [Abstract][Full Text] [Related]
27. 1,3-Diarylcycloalkanopyrazoles and diphenyl hydrazides as selective inhibitors of cyclooxygenase-2.
Sui Z; Guan J; Ferro MP; McCoy K; Wachter MP; Murray WV; Singer M; Steber M; Ritchie DM; Argentieri DC
Bioorg Med Chem Lett; 2000 Mar; 10(6):601-4. PubMed ID: 10741562
[TBL] [Abstract][Full Text] [Related]
28. Pyridazinones as selective cyclooxygenase-2 inhibitors.
Li CS; Brideau C; Chan CC; Savoie C; Claveau D; Charleson S; Gordon R; Greig G; Gauthier JY; Lau CK; Riendeau D; Thérien M; Wong E; Prasit P
Bioorg Med Chem Lett; 2003 Feb; 13(4):597-600. PubMed ID: 12639538
[TBL] [Abstract][Full Text] [Related]
29. Amide derivatives of meclofenamic acid as selective cyclooxygenase-2 inhibitors.
Kalgutkar AS; Rowlinson SW; Crews BC; Marnett LJ
Bioorg Med Chem Lett; 2002 Feb; 12(4):521-4. PubMed ID: 11844663
[TBL] [Abstract][Full Text] [Related]
30. QSAR analysis of some fused pyrazoles as selective cyclooxygenase-2 inhibitors: a Hansch approach.
Prasanna S; Manivannan E; Chaturvedi SC
Arch Pharm (Weinheim); 2004 Aug; 337(8):440-4. PubMed ID: 15293263
[TBL] [Abstract][Full Text] [Related]
31. Design and synthesis of (E)-1,1,2-triarylethenes: novel inhibitors of the cyclooxygenase-2 (COX-2) isozyme.
Uddin MJ; Rao PN; McDonald R; Knaus EE
Bioorg Med Chem Lett; 2005 Jan; 15(2):439-42. PubMed ID: 15603969
[TBL] [Abstract][Full Text] [Related]
32. Discovery of a potent and selective COX-2 inhibitor in the alkoxy lactone series with optimized metabolic profile.
Leblanc Y; Roy P; Wang Z; Li CS; Chauret N; Nicoll-Griffith DA; Silva JM; Aubin Y; Yergey JA; Chan CC; Riendeau D; Brideau C; Gordon R; Xu L; Webb J; Visco DM; Prasit P
Bioorg Med Chem Lett; 2002 Nov; 12(22):3317-20. PubMed ID: 12392741
[TBL] [Abstract][Full Text] [Related]
33. Synthesis of celecoxib analogues possessing a N-difluoromethyl-1,2-dihydropyrid-2-one 5-lipoxygenase pharmacophore: biological evaluation as dual inhibitors of cyclooxygenases and 5-lipoxygenase with anti-inflammatory activity.
Chowdhury MA; Abdellatif KR; Dong Y; Das D; Suresh MR; Knaus EE
J Med Chem; 2009 Mar; 52(6):1525-9. PubMed ID: 19296694
[TBL] [Abstract][Full Text] [Related]
34. 4-Aryl/cycloalkyl-5-phenyloxazole derivatives as selective COX-2 inhibitors.
Hashimoto H; Maeda K; Ozawa K; Haruta J; Wakitani K
Bioorg Med Chem Lett; 2002 Jan; 12(1):65-8. PubMed ID: 11738574
[TBL] [Abstract][Full Text] [Related]
35. 2-hydroxymethyl-4-[5-(4-methoxyphenyl)-3-trifluoromethyl-1H-1-pyrazolyl]-1-benzenesulfonamide (DRF-4367): an orally active COX-2 inhibitor identified through pharmacophoric modulation.
Singh SK; Vobbalareddy S; Kalleda SR; Rajjak SA; Casturi SR; Datla SR; Mamidi RN; Mullangi R; Bhamidipati R; Ramanujam R; Akella V; Yeleswarapu KR
Org Biomol Chem; 2004 Sep; 2(17):2442-50. PubMed ID: 15326524
[TBL] [Abstract][Full Text] [Related]
36. Benzodioxole-Pyrazole Hybrids as Anti-Inflammatory and Analgesic Agents with COX-1,2/5-LOX Inhibition and Antioxidant Potential.
Abd El Razik HA; Badr MH; Atta AH; Mouneir SM; Abu-Serie MM
Arch Pharm (Weinheim); 2017 May; 350(5):. PubMed ID: 28418202
[TBL] [Abstract][Full Text] [Related]
37. Rational design of 6-methylsulfonylindoles as selective cyclooxygenase-2 inhibitors.
Campbell JA; Bordunov V; Broka CA; Browner MF; Kress JM; Mirzadegan T; Ramesha C; Sanpablo BF; Stabler R; Takahara P; Villasenor A; Walker KA; Wang JH; Welch M; Weller P
Bioorg Med Chem Lett; 2004 Sep; 14(18):4741-5. PubMed ID: 15324899
[TBL] [Abstract][Full Text] [Related]
38. Pimarane cyclooxygenase 2 (COX-2) inhibitor and its structure-activity relationship.
Suh YG; Kim YH; Park MH; Choi YH; Lee HK; Moon JY; Min KH; Shin DY; Jung JK; Park OH; Jeon RO; Park HS; Kang SA
Bioorg Med Chem Lett; 2001 Feb; 11(4):559-62. PubMed ID: 11229771
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and anti-inflammatory activity of chalcone derivatives.
Herencia F; Ferrándiz ML; Ubeda A; Domínguez JN; Charris JE; Lobo GM; Alcaraz MJ
Bioorg Med Chem Lett; 1998 May; 8(10):1169-74. PubMed ID: 9871729
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and COX-2 inhibitory properties of N-phenyl- and N-benzyl-substituted amides of 2-(4-methylsulfonylphenyl)cyclopent-1-ene-1-carboxylic acid and of their pyrazole, thiophene and isoxazole analogs.
Rapposelli S; Lapucci A; Minutolo F; Orlandini E; Ortore G; Pinza M; Balsamo A
Farmaco; 2004 Jan; 59(1):25-31. PubMed ID: 14751313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
